{"entity":{"type":"insider","cik":"0001822014","url":"/insider/0001822014","json_url":"/insider/0001822014.json","name":"Cordova Ashley","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":20,"first":"2020-11-03","last":"2025-09-08","span_basis":"filed_date"},"name_variants":[{"name":"Cordova Ashley","source":"filing","n_filings":20,"first_seen":"2020-11-03","last_seen":"2025-09-08"}],"transactions":[{"id":5141019,"accession":"0001562180-25-006130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-006130","line_url":"/filing/0001562180-25-006130#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":81550.0,"shares_display":"81,550","price_per_share":12.2239,"price_display":"12.22","price_state":"stated","total_value":996859.045,"total_display":"996,859.04","shares_owned_after":437569.0,"shares_owned_after_display":"437,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-08","scope":"insider"},{"id":4401519,"accession":"0001562180-25-001975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-001975","line_url":"/filing/0001562180-25-001975#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2053.0,"shares_display":"2,053","price_per_share":18.5363,"price_display":"18.54","price_state":"stated","total_value":38055.0239,"total_display":"38,055.02","shares_owned_after":204005.0,"shares_owned_after_display":"204,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":5139963,"accession":"0001562180-25-001916","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-25-001916","line_url":"/filing/0001562180-25-001916#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2341.0,"shares_display":"2,341","price_per_share":18.2843,"price_display":"18.28","price_state":"stated","total_value":42803.5463,"total_display":"42,803.55","shares_owned_after":206058.0,"shares_owned_after_display":"206,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-03","scope":"insider"},{"id":4443251,"accession":"0001562180-25-001833","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-25-001833","line_url":"/filing/0001562180-25-001833#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2341.0,"shares_display":"2,341","price_per_share":18.2843,"price_display":"18.28","price_state":"stated","total_value":42803.5463,"total_display":"42,803.55","shares_owned_after":206058.0,"shares_owned_after_display":"206,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-03","scope":"insider"},{"id":5139960,"accession":"0001562180-25-001916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-001916","line_url":"/filing/0001562180-25-001916#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9345.0,"shares_display":"9,345","price_per_share":19.9219,"price_display":"19.92","price_state":"stated","total_value":186170.1555,"total_display":"186,170.16","shares_owned_after":210207.0,"shares_owned_after_display":"210,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-03-03","scope":"insider"},{"id":5139956,"accession":"0001562180-25-001916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-001916","line_url":"/filing/0001562180-25-001916#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1808.0,"shares_display":"1,808","price_per_share":20.549,"price_display":"20.55","price_state":"stated","total_value":37152.592,"total_display":"37,152.59","shares_owned_after":208399.0,"shares_owned_after_display":"208,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-03-03","scope":"insider"},{"id":4443247,"accession":"0001562180-25-001833","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-001833","line_url":"/filing/0001562180-25-001833#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9345.0,"shares_display":"9,345","price_per_share":19.9219,"price_display":"19.92","price_state":"stated","total_value":186170.1555,"total_display":"186,170.16","shares_owned_after":210207.0,"shares_owned_after_display":"210,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-03-03","scope":"insider"},{"id":4443239,"accession":"0001562180-25-001833","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-001833","line_url":"/filing/0001562180-25-001833#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1808.0,"shares_display":"1,808","price_per_share":20.549,"price_display":"20.55","price_state":"stated","total_value":37152.592,"total_display":"37,152.59","shares_owned_after":208399.0,"shares_owned_after_display":"208,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-03-03","scope":"insider"},{"id":2729981,"accession":"0001562180-24-005984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-005984","line_url":"/filing/0001562180-24-005984#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":688.0,"shares_display":"688","price_per_share":20.1416,"price_display":"20.14","price_state":"stated","total_value":13857.4208,"total_display":"13,857.42","shares_owned_after":219179.0,"shares_owned_after_display":"219,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-02","filed_date":"2024-08-05","scope":"insider"},{"id":8045451,"accession":"0001562180-23-006686","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-006686","line_url":"/filing/0001562180-23-006686#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":883.0,"shares_display":"883","price_per_share":21.8172,"price_display":"21.82","price_state":"stated","total_value":19264.5876,"total_display":"19,264.59","shares_owned_after":99650.0,"shares_owned_after_display":"99,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":8370213,"accession":"0001562180-23-006182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-006182","line_url":"/filing/0001562180-23-006182#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1144.0,"shares_display":"1,144","price_per_share":30.2511,"price_display":"30.25","price_state":"stated","total_value":34607.2584,"total_display":"34,607.26","shares_owned_after":100533.0,"shares_owned_after_display":"100,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-02","filed_date":"2023-08-04","scope":"insider"},{"id":8449358,"accession":"0001562180-23-002578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-002578","line_url":"/filing/0001562180-23-002578#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4730.0,"shares_display":"4,730","price_per_share":76.1594,"price_display":"76.16","price_state":"stated","total_value":360233.962,"total_display":"360,233.96","shares_owned_after":102085.0,"shares_owned_after_display":"102,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"},{"id":8449354,"accession":"0001562180-23-002578","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-002578","line_url":"/filing/0001562180-23-002578#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":775.0,"shares_display":"775","price_per_share":76.1594,"price_display":"76.16","price_state":"stated","total_value":59023.535,"total_display":"59,023.54","shares_owned_after":101310.0,"shares_owned_after_display":"101,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"},{"id":8038756,"accession":"0001562180-23-002490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-002490","line_url":"/filing/0001562180-23-002490#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1055.0,"shares_display":"1,055","price_per_share":75.2779,"price_display":"75.28","price_state":"stated","total_value":79418.1845,"total_display":"79,418.18","shares_owned_after":95007.0,"shares_owned_after_display":"95,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":7881842,"accession":"0001645113-23-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-23-000027","line_url":"/filing/0001645113-23-000027#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2198.0,"shares_display":"2,198","price_per_share":76.3624,"price_display":"76.36","price_state":"stated","total_value":167844.5552,"total_display":"167,844.56","shares_owned_after":96062.0,"shares_owned_after_display":"96,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":6524872,"accession":"0001645113-22-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000077","line_url":"/filing/0001645113-22-000077#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":885.0,"shares_display":"885","price_per_share":79.037,"price_display":"79.04","price_state":"stated","total_value":69947.745,"total_display":"69,947.74","shares_owned_after":72376.0,"shares_owned_after_display":"72,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider"},{"id":6552207,"accession":"0001645113-22-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000026","line_url":"/filing/0001645113-22-000026#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":759.0,"shares_display":"759","price_per_share":70.1,"price_display":"70.10","price_state":"stated","total_value":53205.9,"total_display":"53,205.90","shares_owned_after":60848.0,"shares_owned_after_display":"60,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-08","filed_date":"2022-03-09","scope":"insider"},{"id":6283428,"accession":"0001645113-22-000022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645113-22-000022","line_url":"/filing/0001645113-22-000022#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":556.0,"shares_display":"556","price_per_share":70.407,"price_display":"70.41","price_state":"stated","total_value":39146.292,"total_display":"39,146.29","shares_owned_after":61607.0,"shares_owned_after_display":"61,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-07","scope":"insider"},{"id":6283425,"accession":"0001645113-22-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-22-000022","line_url":"/filing/0001645113-22-000022#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1149.0,"shares_display":"1,149","price_per_share":74.498,"price_display":"74.50","price_state":"stated","total_value":85598.202,"total_display":"85,598.20","shares_owned_after":62163.0,"shares_owned_after_display":"62,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-07","scope":"insider"},{"id":4834288,"accession":"0001645113-21-000114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000114","line_url":"/filing/0001645113-21-000114#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":209.0,"shares_display":"209","price_per_share":107.276,"price_display":"107.28","price_state":"stated","total_value":22420.684,"total_display":"22,420.68","shares_owned_after":41758.0,"shares_owned_after_display":"41,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider"},{"id":5505229,"accession":"0001645113-21-000108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000108","line_url":"/filing/0001645113-21-000108#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":828.0,"shares_display":"828","price_per_share":138.232,"price_display":"138.23","price_state":"stated","total_value":114456.096,"total_display":"114,456.10","shares_owned_after":41967.0,"shares_owned_after_display":"41,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-07","scope":"insider"},{"id":4910549,"accession":"0001645113-21-000103","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001645113-21-000103","line_url":"/filing/0001645113-21-000103#line-12","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8026.0,"shares_display":"8,026","price_per_share":140.902,"price_display":"140.90","price_state":"stated","total_value":1130879.452,"total_display":"1,130,879.45","shares_owned_after":45993.0,"shares_owned_after_display":"45,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-16","scope":"insider"},{"id":4910546,"accession":"0001645113-21-000103","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001645113-21-000103","line_url":"/filing/0001645113-21-000103#line-11","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7298.0,"shares_display":"7,298","price_per_share":140.9,"price_display":"140.90","price_state":"stated","total_value":1028288.2,"total_display":"1,028,288.20","shares_owned_after":45993.0,"shares_owned_after_display":"45,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-16","scope":"insider"},{"id":4910541,"accession":"0001645113-21-000103","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001645113-21-000103","line_url":"/filing/0001645113-21-000103#line-10","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5927.0,"shares_display":"5,927","price_per_share":141.06,"price_display":"141.06","price_state":"stated","total_value":836062.62,"total_display":"836,062.62","shares_owned_after":45993.0,"shares_owned_after_display":"45,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-16","scope":"insider"},{"id":4910533,"accession":"0001645113-21-000103","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001645113-21-000103","line_url":"/filing/0001645113-21-000103#line-9","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2767.0,"shares_display":"2,767","price_per_share":140.9,"price_display":"140.90","price_state":"stated","total_value":389870.3,"total_display":"389,870.30","shares_owned_after":45993.0,"shares_owned_after_display":"45,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-16","scope":"insider"},{"id":4910525,"accession":"0001645113-21-000103","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001645113-21-000103","line_url":"/filing/0001645113-21-000103#line-8","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2606.0,"shares_display":"2,606","price_per_share":140.9,"price_display":"140.90","price_state":"stated","total_value":367185.4,"total_display":"367,185.40","shares_owned_after":45993.0,"shares_owned_after_display":"45,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-16","scope":"insider"},{"id":4433752,"accession":"0001645113-21-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000046","line_url":"/filing/0001645113-21-000046#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":765.0,"shares_display":"765","price_per_share":130.806,"price_display":"130.81","price_state":"stated","total_value":100066.59,"total_display":"100,066.59","shares_owned_after":35893.0,"shares_owned_after_display":"35,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-08","filed_date":"2021-03-10","scope":"insider"},{"id":5443881,"accession":"0001645113-21-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000037","line_url":"/filing/0001645113-21-000037#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":567.0,"shares_display":"567","price_per_share":137.554,"price_display":"137.55","price_state":"stated","total_value":77993.118,"total_display":"77,993.12","shares_owned_after":37568.0,"shares_owned_after_display":"37,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-08","scope":"insider"},{"id":5339865,"accession":"0001645113-21-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000030","line_url":"/filing/0001645113-21-000030#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":428.0,"shares_display":"428","price_per_share":152.053,"price_display":"152.05","price_state":"stated","total_value":65078.684,"total_display":"65,078.68","shares_owned_after":27249.0,"shares_owned_after_display":"27,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-04","scope":"insider"},{"id":2351144,"accession":"0001645113-20-000158","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-20-000158","line_url":"/filing/0001645113-20-000158#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822014","owner_name":"Cordova Ashley","owner_url":"/insider/0001822014","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230.0,"shares_display":"230","price_per_share":117.411,"price_display":"117.41","price_state":"stated","total_value":27004.53,"total_display":"27,004.53","shares_owned_after":26212.0,"shares_owned_after_display":"26,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645113","name":"NovoCure Ltd","url":"/issuer/0001645113","role":"Officer (Chief Executive Officer)","n_filings":20,"first_seen":"2020-11-03","last_seen":"2025-09-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001822014","retrieved_at":"2026-08-21T22:23:43+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}